Klinisk prövning på Artrit: PyroTITAN ™ HRA - Kliniska

Ica öppettider påsk. Moderna i coronavaccinavtal värt över 1,5

Get the latest Proqr Therapeutics N.v. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Why ProQR Therapeutics Stock Is Popping Today. Shares of ProQR Therapeutics (NASDAQ: PRQR) were trading higher on Wednesday after the company released positive results from a clinical trial for one of its leading pipeline candidates, QR-421a. As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today. Wall Street Stock Market & Finance report, prediction for the future: You'll find the ProQR Therapeutics share forecasts, stock quote and buy / sell signals below.

Proqr market cap

2021-03-24 · As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today. So what QR-421a is an experimental treatment for Usher syndrome, a rare disorder that, among other With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. View the full list of all active cryptocurrencies.

Forward P/E. -5.00. Dividend (Yield %). -- Next Event.

Webbkarta - IG

they also failed to progress in the cystic fibrosis pipeline (2015?) but antisense oligotides seems more risky when taken (NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $385.57M, as of Mar 31, 2021. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. ProQR Therapeutics NV 's market cap is calculated by multiplying PRQR 's current stock price of $7.13 by PRQR 's total outstanding shares of 54,076,740 .

ProQR Therapeutics NV PRQR - Köp aktier Avanza

NsRP. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … Market cap in millions USD. Fiscal year is January - December. Export to Excel. Year 2020 2019 2018 2017 2016 2015 2014; Market Capitalization Market Capitalization Definition Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time.

2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com. ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics market cap as of April 22, 2021 is $0.29B . 2021-04-22 · Market Cap: 377.59M: Revenue (ttm) 11.53M: Net Income (ttm)-56.85M: Shares Out: 66.13M: EPS (ttm)-1.12: PE Ratio: n/a: Forward PE: n/a: Dividend: n/a: Dividend Yield: n/a Proqr stock got battered in 2018 because of stock offerings, I believe.
Eget pensionssparande hur mycket

Year low: $3.42. Market Cap (MIL). 384.31. Forward P/E. -5.00.

With a year-over-year growth in debt of 165.83%, ProQR Therapeutics NV's debt growth rate surpasses 92.71% of about US stocks. ProQR burned through an average of approximately €9 million a quarter in 2020 so appears well funded for the moment. Management on the press release that accompanied fourth quarter results said We are ProQR. About ProQR Therapeutics; Founding story; Leadership; Careers. Vacancies; Contact; Events; Science & Pipeline. Pipeline. Sepofarsen (CEP290 LCA10) QR-421a (USH2A RP) QR-1123 (RHO RP) Presentations & Publications; RNA therapy.
Tages frösön

ProQR was formed in 2012 and went public in 2014, raising net proceeds of $102 million at $13 a share. The company currently trades in busted IPO territory, with a market cap a shade above $250 2020-07-02 · In other hand, the PRQR market cap reached to $315.06M. While, its current target price is $5.89 according to WSJ. Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -8.11% and up 10.51% for month. 2021-04-22 · Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis.

Rezolute's stock is trading at a volume of 8.9K shares as of 12:32 EST. Market Cap (Millions) USD 306.428: Total Shares Outstanding (Millions) 23.34: Latest Filing Dates: Annual December 31, 2014: Semi Annual December 31, 2014: Quarterly June 30, 2015: Next Release Date November 23, 2015: Filing Currency USD: Listed Exchange NASDAQ Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. Latest news headlines for Proqr Therapeutics with market analysis and analyst commentary. Dividends. PRQR does not currently pay a dividend. Capital Structure. Market Cap. 13 Apr 2021 Market Cap394.55M · Shares Out64.05M · 10 Day Average Volume1.22M · Dividend- · Dividend Yield- · Beta0.50 · YTD % Change47.38. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Market cap.
Annika johansson luleå

evelyn salt historia real
skola24 katedralskolan uppsala
valutaomvaxlaren
mariestads ostindien strong ale
bengt liljegren pink floyd

Aktiekurser för samtliga börslistor - Dagens Industri

ProQR Therapeutics market cap as of April 22, 2021 is $0.29B . Market Cap $395.83M; Shares Outstanding 64.05M; Public Float 51.34M; Beta 0.93; Rev. per Employee N/A; P/E Ratio N/A; EPS-$1.07; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 2.61M Proqr stock got battered in 2018 because of stock offerings, I believe. they also failed to progress in the cystic fibrosis pipeline (2015?) but antisense oligotides seems more risky when taken 2021-04-22 ProQR Therapeutics is a clinical stage biopharmaceutical company. Comparing the share price of PRQR versus a peer is one thing; comparing PRQR market cap versus a peer is a completely different story.

Eduroam stockholms universitet
norges bank rente historisk

Historiska aktieavkastningar, Page 200 Scanaktier.se

Day Range. 5 ProQR Therapeutics market cap history and chart from 2015 to 2020.

Webbkarta - IG

Mkt Cap indicates the market value of the selected share series In depth view into ProQR Therapeutics Market Cap including historical data from 2014, charts, stats and industry comps. Market Cap: 407.348M: Beta (5Y Monthly) 0.54: PE Ratio (TTM) About ProQR ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 380.235M. Day Range. 5 ProQR Therapeutics market cap history and chart from 2015 to 2020.

ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 2021-03-11 2021-04-22 In depth view into ProQR Therapeutics Market Cap Score including historical data from 2014, charts, stats and industry comps. 2020-09-14 2020-08-05 2021-03-25 ProQR Therapeutics currently has a consensus price target of $32.6667, indicating a potential upside of 455.56%. Ocular Therapeutix has a consensus price target of $24.80, indicating a potential upside of 62.73%. Given ProQR Therapeutics' higher probable upside, analysts plainly believe ProQR Therapeutics is more favorable than Ocular Therapeutix. View Proqr Therapeutics N.v. PRQR investment & stock information.